Revolution Medicines Drug Shows Promising Phase 3 Cancer Trial Results

Revolution Medicines announced positive Phase 3 trial results for its new orally administered drug, offering hope to patients battling a particularly aggressive form of cancer. The promising outcomes led to a significant increase in the company's stock value.